DBV Technologies (DBVT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on DBV Technologies (DBVT) is Neutral.

The composite score behind that read is -0.15, weighing +0.02 of bullish evidence against -0.33 bearish.

DBV Technologies last closed at $9.80, +2.62% on the session.

Against the IVW growth benchmark the position is +1.82% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

18 graded predictions for DBVT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks DBV Technologies in the 9th percentile on return on equity, where 100 is best.

DBV Technologies is classified under Health Care / Biotechnology, with a market capitalisation of $600.17M.

StockMap tracks DBV Technologies as the 167th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite DBV Technologies ranks 283rd of 381 in the group, against a group median of -0.08.